Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Binimetinib in Pediatric Adamantinomatous Craniopharyngioma
NCT05286788Phase 2Recruiting
- Sponsor
- Nationwide Children's Hospital
- Start
- Apr 2023
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of binimetinib in craniopharyngioma, sponsored by Nationwide Children's Hospital. Started Apr 2023; status: recruiting.
02
Drugs
binimetinib
03
Conditions
craniopharyngioma
Beyond the preview
Go deeper on NCT05286788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05286788.